Dec 18, 2013 LabStyle on track with 2014 global roll-out plans for the Dario™ diabetes management platform LabStyle Innovations Corp. (OTCQB:DRIO), developer of Dario™, a cloud-based, mobile health platform for diabetes and blood glucose monitoring,...
|
Dec 12, 2013 Commercial roll-out of Dario™ expected to continue in 2014 with the soft launch of the Dario™ software and the 'all-in-one', pocket-sized, Dario™ blood glucose monitoring device, in select markets LabStyle Innovations Corp. (OTCQB: DRIO), developer of Dario™, a cloud-based, mobile health (mHealth) platform for diabetes and related blood...
|
Nov 27, 2013 Experienced public company CFO augments LabStyle's senior management capabilities as the company moves towards commercial launch of Dario™ LabStyle Innovations Corp. (OTCQB:DRIO), developer of Dario™, a cloud-based, mobile health (mHealth) platform for diabetes management and...
|
Nov 19, 2013 Coming soon to New Zealand - the Dario iOS app on December 12, 2013; the Dario Android app and the Dario blood glucose monitoring device during...
|
Nov 19, 2013 Coming soon to New Zealand - the Dario iOS app on December 12, 2013; the Dario Android app and the Dario blood glucose monitoring device during first quarter of 2014 LabStyle Innovations Corp. (OTCQB:DRIO), developer of Dario™, a cloud-based, mobile health (mHealth) platform for diabetes and related blood...
|
Nov 14, 2013 Senior medical device industry, public company and accounting expert expands the capabilities of LabStyle's Board LabStyle Innovations Corp. (OTCQB: DRIO), developer of Dario™, a cloud-based, mobile health (mHealth) platform for diabetes and related blood...
|
Nov 12, 2013 Following grant in third quarter of CE Mark for the Dario™ diabetes management platform, global roll-out of Dario begins on December 12, 2013 with launch of free Dario™ iOS App in UK, NZ and Australia followed by Italy and Belgium in first quarter 2014; LabStyle Innovations Corp. (OTCQB/OTCBB: DRIO), developer of Dario™, a cloud-based, mobile health (mHealth) platform for diabetes management and...
|
Nov 4, 2013 The European launch of the iOS mobile app is the first phase of a worldwide roll-out of the full Dario™ platform Ramat Gan, Israel, November 4, 2013 --- LabStyle Innovations Corp. (OTCQB:DRIO), developer of Dario™, a cloud-based, mobile health (mHealth) platform for diabetes and related blood glucose...
|
Sep 23, 2013 Initial European soft launch to begin in the coming months Dario app to be available to non-Dario device users in Europe in the near future Company to accelerate efforts in pursuit of U.S. FDA 510(k) clearance while exploring other geographies RAMAT GAN,...
|
Sep 18, 2013 RAMAT GAN, Israel (September 18, 2013) – LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ smartphone-based medical device and diabetes management system, announces that...
|
Aug 12, 2013 Moves underscore evolution from R&D to commercial-stage enterprise Moves underscore evolution from R&D to commercial-stage enterprise
|
Jun 25, 2013 Appointment of Dr. Itamar Raz of Hadassah Medical Center strengthens board’s medical and research expertise CHICAGO and RAMAT GAN, Israel (June 25, 2013) – LabStyle Innovations Corp. (OTCQB: DRIO), the developer of the Dario™ smartphone-based diabetes medical device and data management system,...
|
Jun 24, 2013 Provider of specialized and comprehensive diabetes solutions to begin sales and marketing activities upon receipt of CE mark CHICAGO and RAMAT GAN, Israel (June 24, 2013) – LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ smartphone-based glucose monitor and diabetes data-management system,...
|
Jun 20, 2013 Webcast of company presentation begins at 10:20 a.m. Eastern time on June 27 RAMAT GAN, Israel--(BUSINESS WIRE)--LabStyle Innovations Corp. (OTCQB: DRIO), an emerging leader in mobile health (mHealth) and developer of the Dario™ smartphone-based
|
Jun 3, 2013 Mikael Salo to establish new Nordic headquarters in Helsinki ahead of anticipated 2013 European commercial launch of Dario RAMAT GAN, Israel (June 3, 2013) – LabStyle Innovations Corp. (OTCQB: DRIO), an emerging leader in the mobile health (mHealth) sector and developer of the Dario™ smartphone-based diabetes
|
May 14, 2013 Company makes significant strides in progressing Dario towards anticipated market launch, pending regulatory approvals RAMAT GAN, Israel (May 14, 2013) – LabStyle Innovations Corp. (OTCQB/OTCBB: DRIO), developer of the Dario™ smartphone-based medical device and diabetes management system, today reported...
|
May 10, 2013 Funds will support the anticipated European launch of Dario upon receipt of regulatory clearance RAMAT GAN, Israel (May 10, 2013) – LabStyle Innovations Corp. (OTCQB:DRIO), developer of the Dario™ smartphone-based medical device and diabetes management system, announces the final...
|
Apr 25, 2013 Advances strategy for commercialization of smartphone-powered blood glucose monitor upon receipt of CE mark RAMAT GAN, Israel (April 25, 2013) – LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ smartphone-based diabetes management system, announces
|
Apr 22, 2013 RAMAT GAN, Israel (April 22, 2013) – LabStyle Innovations Corp. (OTCQB: DRIO)...
|
RAMAT GAN, Israel--(BUSINESS WIRE)-- LabStyle Innovations Corp. (DRIO), developer of the Dario™ smartphone-based diabetes management system, announces that its common stock is now trading on the...
|
|